Company Update GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Opthalmic Solution, 0.2% / 0.5%